ATH 0.00% 0.4¢ alterity therapeutics limited

Regal fund management, page-8

  1. 2,808 Posts.
    lightbulb Created with Sketch. 974
    If you are "a short-selling king", is it worth buying suddenly and then owning 12,9 % of the company listed in Australia? I have thought that short selling in Australia has some limitations in comparison to the USA. I would think that in spite of skills in short selling a fund needs to accumulate the value of their portfolio at least when you own 12.9% of a particular company. I think that "short selling kings" are risk-takers, more than average investors are. In that way, they are similar to us present ATH investors as nobody knows if ATH434 works in MSA patients, PBT2 works in human cardiac light chain amyloidosis, or kills the bacteria causing human antibiotic-resistant infections or if and how the patents can secure royalties to the company.
    But I do not know much about short selling. 12.9% is a lot and so we will be reported if this number will increase or decrease every now and then. Will be interesting in both ways.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $8.4K 2.1M

Buyers (Bids)

No. Vol. Price($)
67 79035427 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 115463117 7
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.